DOMO vs JNJ · rev $318.9M vs P/E 17, rev $49.37B
Domo Inc (DOMO) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Domo Inc (DOMO) is a software - application company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported DOMO revenue for 2026-01-31 was $318.9M. Net income was -$59.3M. Revenue was up 0.6% from 2025-01-31 to 2026-01-31. DOMO currently screens at market cap $559.7M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
DOMO currently screens at market cap $559.7M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the DOMO and JNJ stock pages for the full models.
Not investment advice.